Effects of dose and schedule on the efficacy of ethyol: Preclinical studies

被引:19
作者
Cassatt, DR
Fazenbaker, CA
Kifle, G
Bachy, CM
机构
[1] Medimmune Inc, Dept Canc Biol, Gaithersburg, MD 20878 USA
[2] Medimmune Inc, Dept Mol Biol Biochem, Gaithersburg, MD 20878 USA
关键词
D O I
10.1053/j.seminoncol.2003.11.039
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:31 / 39
页数:9
相关论文
共 30 条
  • [1] Phase II trial of subcutaneous amifostine in patients undergoing radiation therapy for head and neck cancer
    Anné, PR
    [J]. SEMINARS IN ONCOLOGY, 2002, 29 (06) : 80 - 83
  • [2] A phase II trial of subcutaneous Amifostine and radiation therapy in patients with head and neck cancer
    Anné, PR
    Curran, WJ
    [J]. SEMINARS IN RADIATION ONCOLOGY, 2002, 12 (01) : 18 - 19
  • [3] Measurement of both protein-bound and total S-2-(3-aminopropylamino)ethanethiol (WR-1065) in blood by high-performance liquid chromatography
    Bonner, HS
    Shaw, LM
    [J]. JOURNAL OF CHROMATOGRAPHY B, 2000, 739 (02): : 357 - 362
  • [4] New dosing regimens for amifostine: A pilot study to compare the relative bioavailability of oral and subcutaneous administration with intravenous infusion
    Bonner, HS
    Shaw, LM
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 42 (02) : 166 - 174
  • [5] Phase III randomized trial of amifostine as a radioprotector in head and neck cancer
    Brizel, DM
    Wasserman, TH
    Henke, M
    Strnad, V
    Rudat, V
    Monnier, A
    Eschwege, F
    Zhang, J
    Russell, L
    Oster, W
    Sauer, R
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (19) : 3339 - 3345
  • [6] Amifostine in simultaneous radiochemotherapy of advanced head and neck cancer
    Büntzel, J
    Glatzel, M
    Kuttner, K
    Weinaug, R
    Fröhlich, D
    [J]. SEMINARS IN RADIATION ONCOLOGY, 2002, 12 (01) : 4 - 13
  • [7] Capizzi RL, 1999, SEMIN ONCOL, V26, P3
  • [8] Subcutaneous administration of amifostine (Ethyol) is equivalent to intravenous administration in a rat mucositis model
    Cassatt, DR
    Fazenbaker, CA
    Kifle, G
    Bachy, CM
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2003, 57 (03): : 794 - 802
  • [9] Preclinical studies on the radioprotective efficacy and pharmacokinetics of subcutaneously administered amifostine
    Cassatt, DR
    Fazenbaker, CA
    Kifle, G
    Bachy, CM
    [J]. SEMINARS IN ONCOLOGY, 2002, 29 (06) : 2 - 8
  • [10] Preclinical modeling of improved amifostine (Ethyol) use in radiation therapy
    Cassatt, DR
    Fazenbaker, CA
    Bachy, CM
    Hanson, MS
    [J]. SEMINARS IN RADIATION ONCOLOGY, 2002, 12 (01) : 97 - 102